Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Q2 2024 Earnings Call Transcript August 1, 2024
Ionis Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.45, expectations were $-0.95.
Operator: Good morning, and welcome to the Ionis Second Quarter 2024 Financial Results Conference Call. As a reminder, this call is being recorded. At this time, I would like to turn the call over to Wade Walke, Senior Vice President of Investor Relations, to lead off the call. Please begin.
Wade...
